ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,831
Screening encounters
1,962
Diagnostic referrals
377
Outstanding pathways
166

Screening pathway

  1. Screening1,962Encounters
  2. Positive finding661Documented findings
  3. Referral377Diagnostic referrals
  4. Follow-up407Diagnostic visits
  5. Outcome211Resolved pathways

Stage totals use different units. Pending pathways: 166. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0803 · EXP-0803Synthetic · Site D

Full participant history through 2025-11-27, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-11-06

Referral-time risk

No matching referral was available at this observation date.

Screened participants

1831 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4574 · Expanded synthetic participant 4574Site D — Community Engagement Programme
EXP-4575 · Expanded synthetic participant 4575Site B — Peri-Urban Access Programme
EXP-4579 · Expanded synthetic participant 4579Site E — Resource-Constrained Navigation Programme
EXP-4582 · Expanded synthetic participant 4582Site D — Community Engagement Programme
EXP-4585 · Expanded synthetic participant 4585Site D — Community Engagement Programme
EXP-4586 · Expanded synthetic participant 4586Site C — Rural Outreach Programme
EXP-4587 · Expanded synthetic participant 4587Site E — Resource-Constrained Navigation Programme
EXP-4590 · Expanded synthetic participant 4590Site E — Resource-Constrained Navigation Programme
EXP-4594 · Expanded synthetic participant 4594Site D — Community Engagement Programme
EXP-4597 · Expanded synthetic participant 4597Site E — Resource-Constrained Navigation Programme
EXP-4600 · Expanded synthetic participant 4600Site D — Community Engagement Programme
EXP-4603 · Expanded synthetic participant 4603Site D — Community Engagement Programme
EXP-4607 · Expanded synthetic participant 4607Site A — Urban Referral Hub
EXP-4609 · Expanded synthetic participant 4609Site C — Rural Outreach Programme
EXP-4611 · Expanded synthetic participant 4611Site E — Resource-Constrained Navigation Programme
EXP-4612 · Expanded synthetic participant 4612Site A — Urban Referral Hub
EXP-4613 · Expanded synthetic participant 4613Site D — Community Engagement Programme
EXP-4614 · Expanded synthetic participant 4614Site B — Peri-Urban Access Programme
EXP-4615 · Expanded synthetic participant 4615Site C — Rural Outreach Programme
EXP-4617 · Expanded synthetic participant 4617Site B — Peri-Urban Access Programme
EXP-4619 · Expanded synthetic participant 4619Site B — Peri-Urban Access Programme
EXP-4620 · Expanded synthetic participant 4620Site E — Resource-Constrained Navigation Programme
EXP-4621 · Expanded synthetic participant 4621Site D — Community Engagement Programme
EXP-4627 · Expanded synthetic participant 4627Site C — Rural Outreach Programme
EXP-4629 · Expanded synthetic participant 4629Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
837
HPV DNA
843
Cytology
282

Navigation activity

Barrier documented
308
Contact attempt
548
Navigation intervention
125
Diagnostic booking
451
Diagnostic visit
407

Documented barriers

Contact difficulty
93
Transport difficulty
103
Appointment coordination
112

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.